Timothy P. Clackson
2022
In 2022, Timothy P. Clackson earned a total compensation of $4.4M as President, Chief Executive Officer and Director at Theseus Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,500 |
|---|---|
| Option Awards | $3,451,050 |
| Salary | $570,000 |
| Other | $16,790 |
| Total | $4,351,340 |
Clackson received $3.5M in option awards, accounting for 79% of the total pay in 2022.
Clackson also received $313.5K in non-equity incentive plan, $570K in salary and $16.8K in other compensation.
Rankings
In 2022, Timothy P. Clackson's compensation ranked 769th out of 5,759 executives tracked by ExecPay. In other words, Clackson earned more than 86.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 769 out of 5,759 | 87th |
Division Manufacturing | 346 out of 3,135 | 89th |
Major group Chemicals And Allied Products | 114 out of 1,421 | 92nd |
Industry group Drugs | 101 out of 1,322 | 92nd |
Industry Pharmaceutical Preparations | 74 out of 968 | 92nd |
Source: SEC filing on April 26, 2023.
Clackson's colleagues
We found two more compensation records of executives who worked with Timothy P. Clackson at Theseus Pharmaceuticals in 2022.